| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(97)12308-X |
| P698 | PubMed publication ID | 9746040 |
| P2093 | author name string | A F Hahn | |
| P2860 | cites work | An Unusual Variant of Acute Idiopathic Polyneuritis (Syndrome of Ophthalmoplegia, Ataxia and Areflexia) | Q22250915 |
| Assessment of current diagnostic criteria for Guillain-Barré syndrome | Q22252936 | ||
| Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome | Q28256385 | ||
| Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection | Q28284306 | ||
| The Guillain-Barré syndrome | Q28291904 | ||
| Treatment related fluctuations in Guillain-Barré syndrome after high-dose immunoglobulins or plasma-exchange | Q33590031 | ||
| A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value | Q33631043 | ||
| A prospective study of acute idiopathic neuropathy. II. Antecedent events | Q33631049 | ||
| Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study Group | Q34396132 | ||
| Guillain-Barré syndrome in northern China Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies | Q34720415 | ||
| Electrophysiological changes in the acute "axonal" form of Guillain-Barre syndrome | Q34730294 | ||
| Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. | Q34731153 | ||
| Epidemiological features of Guillain-Barré syndrome in Sweden, 1978-93 | Q36904993 | ||
| A clinicopathological study of the Guillain-Barré syndrome. Nine cases and literature review | Q37774918 | ||
| Electrophysiology in Guillain-Barré syndrome | Q37937978 | ||
| A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure | Q38314715 | ||
| The incidence of Guillain-Barre syndrome in Ferrara, Italy: is the disease really increasing? | Q39443907 | ||
| Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases | Q40438026 | ||
| Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part I. | Q40571159 | ||
| Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II. | Q40571167 | ||
| The immunopathogenesis of multiple sclerosis and Guillain-Barré syndrome. | Q41137934 | ||
| Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside | Q41608044 | ||
| Pseudoaxonal Guillain-Barré syndrome: severe demyelination mimicking axonopathy. A case with pupillary involvement | Q41621235 | ||
| Clinical and epidemiologic features of Guillain-Barré syndrome | Q41660313 | ||
| Epidemiologic and clinical features of Campylobacter jejuni infections | Q41660326 | ||
| Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome | Q41660366 | ||
| Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome | Q41664465 | ||
| Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barre syndrome | Q41838846 | ||
| Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988. | Q41890248 | ||
| Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry | Q42277583 | ||
| Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome | Q42524808 | ||
| Antibody to GalNAc-GD1a and GalNAc-GM1b in Guillain-Barré syndrome subsequent to Campylobacter jejuni enteritis | Q42551712 | ||
| Assessment of Guillain-Barré syndrome mortality and morbidity in the United States: implications for acute flaccid paralysis surveillance | Q44139230 | ||
| Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome | Q44664722 | ||
| Guillain-Barré syndrome in the United States, 1978-1981: additional observations from the national surveillance system | Q44998783 | ||
| Serotype of Campylobacter jejuni, HLA, and the Guillain-Barré syndrome | Q45191246 | ||
| Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome | Q48110038 | ||
| An acute axonal form of Guillain-Barré polyneuropathy | Q48268785 | ||
| Selective staining of the cerebellar molecular layer by serum IgG in Miller-Fisher and related syndromes | Q48881651 | ||
| Measles vaccination and Guillain-Barré syndrome. | Q50619044 | ||
| Epidemiologic study of Guillain-Barré syndrome in children <15 years of age in Latin America. | Q50623150 | ||
| Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome. | Q50627771 | ||
| Multifocal motor neuropathy human sera block distal motor nerve conduction in mice | Q51600026 | ||
| Motor conduction studies in Guillain-Barré syndrome: description and prognostic value. | Q54546275 | ||
| Campylobacter jejuni infection and Guillain-Barré syndrome. | Q55063212 | ||
| Patterns of recovery in the Guillain-Barre syndromes | Q57197739 | ||
| Acute motor axonal neuropathy: An antibody-mediated attack on axolemma | Q57197741 | ||
| Immune attack on the schwann cell surface in acute inflammatory demyelinating polyneuropathy | Q57197743 | ||
| Pathology of the motor-sensory axonal Guillain-Barré syndrome | Q57197745 | ||
| Reassessment of the Association between Guillain-Barré Syndrome and Receipt of Swine Influenza Vaccine in 1976–1977: Results of a Two-State Study | Q64128491 | ||
| Electrophysiologic studies in the Guillain-Barré syndrome: Effects of plasma exchange and antibody rebound | Q67734451 | ||
| Acute motor neuropathy with antibodies to GM1 ganglioside | Q67835411 | ||
| Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome | Q67976799 | ||
| A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group | Q68081121 | ||
| Plasma exchange in Guillain-Barré syndrome: one-year follow-up. French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome | Q68231844 | ||
| Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome | Q68257606 | ||
| Plasmapheresis and Guillain-Barré syndrome: analysis of prognostic factors and the effect of plasmapheresis | Q68405755 | ||
| Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis | Q68614125 | ||
| Immunostaining of motor nerve terminals by IgM M protein with activity against gangliosides GM1 and GD1b from a patient with motor neuron disease | Q69047339 | ||
| Experiences with Guillain-Barré syndrome in a pediatric intensive care unit | Q69400886 | ||
| Efficiency of plasma exchange in Guillain-Barré syndrome: role of replacement fluids. French Cooperative Group on Plasma Exchange in Guillain-Barré syndrome | Q69913180 | ||
| Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies | Q70514545 | ||
| Differential expression of gangliosides on the surfaces of myelinated nerve fibers | Q70679266 | ||
| Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome | Q70705683 | ||
| Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain beta-N-acetylglucosamine residues | Q70729735 | ||
| Pathology of the Guillain-Barr� syndrome | Q70751954 | ||
| The axon in Guillain-Barré syndrome: immune target or innocent bystander? | Q70928201 | ||
| Vaccines and Guillain-Barré syndrome | Q71146324 | ||
| Conduction block and denervation in Guillain-Barré polyneuropathy | Q71270566 | ||
| Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome | Q71444464 | ||
| Association of anti-GM2 antibodies in Guillain-Barré syndrome with acute cytomegalovirus infection | Q71477649 | ||
| Antibodies against sulfated glycosphingolipids of peripheral nerve myelins detected in patients with human cytomegalovirus infection | Q71656746 | ||
| Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group | Q72012221 | ||
| Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers | Q72157843 | ||
| The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis | Q72350602 | ||
| Treatment of Guillain-Barré syndrome with high-dose immune globulins combined with methylprednisolone: a pilot study. The Dutch Guillain-Barré Study Group | Q72533936 | ||
| Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release | Q72667720 | ||
| Severe axonal degeneration in acute Guillain-Barré syndrome: evidence of two different mechanisms? | Q72843312 | ||
| Appropriate number of plasma exchanges in Guillain-Barré syndrome. The French Cooperative Group on Plasma Exchange in Guillain-Barré Syndrome | Q73146689 | ||
| Fulminant Guillain-Barré syndrome with universal inexcitability of peripheral nerves: a clinicopathological study | Q73405045 | ||
| Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome | Q73515431 | ||
| Association between oral poliovaccine and Guillain-Barré syndrome? | Q74078859 | ||
| Characterization of Campylobacter jejuni isolates from patients with Guillain-Barré syndrome | Q74142844 | ||
| HIV seropositivity in Guillain-Barré syndrome | Q93557069 | ||
| Guillain-Barré syndrome. Clinicoepidemiologic features and effect of influenza vaccine | Q93629280 | ||
| P433 | issue | 9128 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Guillain–Barré syndrome | Q205214 |
| P304 | page(s) | 635-641 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Guillain-Barré syndrome | |
| P478 | volume | 352 |
| Q37618626 | A Rare case of Guillain-Barré syndrome in pregnancy treated with plasma exchange |
| Q33893976 | A case of diabetic neuropathy combined with Guillain-Barre syndrome |
| Q37320264 | A case-case comparison of Campylobacter coli and Campylobacter jejuni infection: a tool for generating hypotheses. |
| Q40208214 | A clinical prognostic scoring system for Guillain-Barré syndrome |
| Q84071091 | Acute encephalopathy associated with Campylobacter jejuni enteritis |
| Q40597830 | Acute motor axonal neuropathy and aseptic meningitis due to Staphylococcus aureus endocarditis |
| Q33399805 | Acute neuromuscular weakness associated with dengue infection |
| Q41086512 | Acute renal failure, severe sodium and potassium imbalance and sudden tetraplegia |
| Q57821737 | An Unusual Presentation of Acute Weakness: Acute Inflammatory Demyelinating Polyneuropathy in a Patient with Psychiatric Illness |
| Q36862161 | Anti-GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis |
| Q46619173 | Anti-phospholipid antibodies in serum from patients with Guillain-Barré syndrome. |
| Q34574505 | Antibodies against gangliosides: a link between preceding infection and immunopathogenesis of Guillain-Barré syndrome |
| Q73094182 | Antibody responses in the Guillain-Barré syndrome |
| Q47933107 | Anti–GM1 IgG antibodies induce leukocyte effector functions via Fcγ receptors |
| Q51340044 | Assessment of experimental autoimmune neuritis in the rat by electrophysiology of the tail nerve. |
| Q56341831 | Augmented Zika and dengue neutralizing antibodies are associated with Guillain-Barré syndrome |
| Q92436546 | Bumbling, Stumbling, Fumbling: Weakness, Steppage Gait, and Facial Droop in a 3-Year-Old Male |
| Q94601172 | COVID-19 and molecular mimicry: The Columbus' egg? |
| Q33767329 | Campylobacter jejuni. |
| Q28296591 | Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome |
| Q38914130 | Coexisting infectious diseases on admission as a risk factor for mechanical ventilation in patients with Guillain-Barré syndrome. |
| Q34955839 | Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective |
| Q77958559 | Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay |
| Q39488773 | Detection on surfaces and in Caco-2 cells of Campylobacter jejuni cells transformed with new gfp, yfp, and cfp marker plasmids |
| Q34451647 | Development of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimics |
| Q42532547 | Development of recurrent facial palsy during plasmapheresis in Guillain-Barré syndrome: a case report |
| Q44738594 | Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial |
| Q51376386 | Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome. |
| Q98205269 | Emergence and significance of carbohydrate-specific antibodies |
| Q51676302 | Epidemiology of Guillain-Barré syndrome in the province of Quebec. |
| Q38429315 | Evaluation of Salmonella-vectored Campylobacter peptide epitopes for reduction of Campylobacter jejuni in broiler chickens |
| Q61806284 | Extending statistical models for source attribution of zoonotic diseases: a study of campylobacteriosis |
| Q35220367 | Ganglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseases |
| Q36994582 | Gangliosides as targets for autoimmune injury to the nervous system |
| Q37345583 | Guillain Barre syndrome as a manifestation of neurological melioidosis |
| Q40274224 | Guillain-Barre syndrome in a patient with diffuse large B-cell lymphoma, and rituximab maintenance therapy. An association beyond anecdotal evidence? |
| Q73239553 | Guillain-Barré Syndrome |
| Q98290213 | Guillain-Barré Syndrome Secondary to West Nile Virus in New York City |
| Q34117850 | Guillain-Barré syndrome (GBS). |
| Q34605194 | Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation |
| Q40277649 | Guillain-Barré syndrome associated with pulmonary tuberculosis |
| Q73711209 | Guillain-Barré syndrome complicated with hemolytic anemia in association with antiganglioside GM3 antibody |
| Q59238417 | Guillain-Barré syndrome complicating dengue fever: Two case reports |
| Q43767021 | Guillain-Barré syndrome secondary to cranial surgery: direct or fortuitous relationship? |
| Q35690159 | Guillain-Barré syndrome: epidemiology, pathophysiology and management |
| Q36099279 | Guillaine-barre syndrome; a rare complication of melioidosis. a case report |
| Q37790256 | Guillain–Barré syndrome: a review |
| Q36934115 | Herpes simplex virus meningitis complicated by ascending paralysis. |
| Q35640543 | Immunotherapy for Guillain-Barré syndrome |
| Q42054398 | In silico proposition to predict cluster of B- and T-cell epitopes for the usefulness of vaccine design from invasive, virulent and membrane associated proteins of C. jejuni |
| Q30355745 | Increased Guillain-Barre syndrome admissions in Shiraz, southern Iran. |
| Q37862292 | Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study |
| Q59273820 | Intrathecal anti-αB-crystallin IgG antibody responses: Potential inflammatory markers in Guillain-Barré syndrome |
| Q43601492 | Is there a decrease in Guillain-Barré syndrome incidence after bovine ganglioside withdrawal in Italy? A population-based study in the Local Health District of Ferrara, Italy. |
| Q35806480 | Long-term health risks for children and young adults after infective gastroenteritis. |
| Q64131882 | MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach |
| Q34127075 | Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies |
| Q33853670 | Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. |
| Q77707530 | Motor conduction studies in Miller Fisher syndrome with severe tetraparesis |
| Q24234676 | Multidisciplinary care for Guillain-Barré syndrome |
| Q24235671 | Multidisciplinary care for Guillain-Barré syndrome |
| Q58724322 | Multifocal motor neuropathy presenting as a post-infectious complication of dengue: a CASE report |
| Q46245795 | Nanobodies targeting conserved epitopes on the major outer membrane protein of Campylobacter as potential tools for control of Campylobacter colonization |
| Q79918469 | Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome |
| Q42915667 | Occurrence of Guillain-Barré syndrome as an immune mediated complication after thrombolysis with streptokinase for acute anterior wall myocardial infarction: a caution to be vigilant |
| Q48213941 | Primary Cytomegalovirus Infection Causing Guillain-Barré Syndrome in a Living Renal Allograft Recipient. |
| Q51648064 | Prospective study of clinical epidemiology of Guillain–Barré syndrome in Harbin, China |
| Q40134813 | Secondary membranous nephropathy associated with guillain-barré syndrome |
| Q34658942 | Selective immune adsorption treatment of severe Guillain Barré syndrome in the intensive care unit |
| Q73321343 | Series 4: respiratory muscles in neuromuscular diseases and the chest cavity. The function of respiratory muscles in neuromuscular diseases |
| Q44634755 | Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome |
| Q79796061 | Temporal coincidence between AMAN type of GBS and myasthenia gravis |
| Q37436632 | The Biology of Persistent Infection: Inflammation and Demyelination following Murine Coronavirus Infection of the Central Nervous System |
| Q33497046 | The epidemiology of Guillain-Barré Syndrome in U.S. military personnel: a case-control study |
| Q33850688 | The immunopathogenesis of Miller Fisher syndrome |
| Q21328672 | The role of apolipoprotein E in Guillain-Barré syndrome and experimental autoimmune neuritis |
| Q37812002 | The role of cytokines in Guillain–Barré syndrome |
| Q34175763 | The role of macrophages in immune-mediated damage to the peripheral nervous system |
| Q51649869 | The ventilated patient undergoing hydrotherapy: a case study |
| Q34129949 | Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome |
| Q34318837 | Treatment approaches for Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy |
| Q35174362 | Treatment-related fluctuation in Guillain-Barre syndrome |
| Q96298291 | Two case reports of distal upper limb weakness following influenza-like illness: an emerging pattern of para-infectious myositis in adults |
| Q77632144 | [Guillain-Barre syndrome] |
| Q81012333 | [Neurologic emergencies] |
| Q79703344 | [Plasma exchange as a therapeutic option in neurological disorders] |
Search more.